Latest News
These are CLL Ireland’s latest news posts from Facebook – but make sure to visit our CLL Ireland Facebook page for older posts.
HSE Update regarding the booster shot for our community. This is the 4th dose. ![]()
![]()
COVID-19 booster for people with weak immune systems: People who have a weak immune system, also called immunocompromised, can now get a booster dose. People in this group were offered a third dose of the COVID-19 vaccine, and can now get a booster dose if it has been 3 months since their third dose. See below for information on how to get your booster dose - you can use any of the options outlined in the next section.![]()
![]()
COVID-19 vaccine booster![]()
![]()
People aged 16 and older can get their COVID-19 vaccine booster dose now. Find more information on the different options you have to get your vaccine booster .![]()
scanner.topsec.com/?d=2120&r=show&t=b4b1275697ea9d9d0a19d3fac3ff6026341214cc&u=https%3A%2F%2Fwww2...![]()
You can book your own booster appointment for many vaccination centres online through the HSE website using the online self-scheduler here.![]()
![]()
www2.hse.ie/screening-and-vaccinations/covid-19-vaccine/get-the-vaccine/booster-booking/![]()
You can also get your booster at many pharmacies and you’ll find a list on HSE.ie .![]()
www.hse.ie/eng/![]()
![]()
Some GPs are also vaccinating their patients.![]()
![]()
You need to wait at least 3 months (90 days) after your vaccine course before you can get a booster dose. If you have had COVID-19 since you were vaccinated you should get your booster dose at least 3 months after your positive result.![]()
![]()
Please bring photo ID that shows your date of birth to your appointment or walk-in clinic.
This will be of interest to our community. ![]()
![]()
SAVE THE DATE : Highlights from ASH - CLL![]()
Hosts: @LeukaemiaCareUK & @CLLAdvocates ![]()
Speaker: Dr Piers Patten![]()
Date: Feb 11th, 4.30-6pm CET![]()
![]()
Chronic Lymphocytic Leukaemia Advocates Network and Leukaemia Care are delighted to announce our collaborative webinar for patients, family members, carers and advocates.![]()
![]()
This webinar is aimed at patients and advocates to provide an overview of latest developments in the treatment of CLL that were presented at The American Society of Haematology (ASH) Conference in Georgia, US, December 2021![]()
![]()
We will be joined by:![]()
Dr Piers Patten - Consultant Haematologist and Senior Lecturer, Kings College Hospital NHS Foundation Trust![]()
![]()
us02web.zoom.us/webinar/register/WN_Gn_XT8nMRL6Y-Qy0Jsz-Lw
us02web.zoom.us
This webinar is aimed at patients and advocates to provide an overview of latest developments in the treatment of CLL that were presented at The American Society of Haematology (ASH) Conference in Geo... CLL Ireland was interviewed recently in the Business Post about the new antivirals treatments. ![]()
![]()
These drugs were approved on the December 12. We need this pill now,” Michael Rynne, communications officer for CLL Ireland, said. “A large proportion of the population will be infected or exposed by the end of the month, increasing the risk to high risk cancer patients.![]()
![]()
www.businesspost.ie/coronavirus/anti-viral-covid-pills-should-be-made-available-to-cancer-patient...
Anti-viral Covid pills should be made available to cancer patients, charity says | Business Post
www.businesspost.ie
New treatments such as Paxlovid can reduce the risk of hospitalisation and death in high risk coronavirus patients by 89 per cent Currently in Ireland medically vulnerable patients have no protection and no plan if they contract covid ![]()
UK patients have received letters from NHS detailing how they are to access the covid treatments.![]()
![]()
This shows our vulnerable community is not prioritised and our government needs to do more. ![]()
Omicron is at very high levels and patients are at risk.![]()
![]()
t.co/xzEjrhxFGb
Good news for CLL patients with this new drug![]()
Pirtobrutinib (LOXO-305)![]()
![]()
Ireland still falls short on our drug approval but hopefully 2022 our patients who need treatment will get the access they deserve.![]()
![]()
www.mskcc.org/news/researchers-report-good-outcomes-new-leukemia-and-lymphoma-drug
Researchers Report Excellent Outcomes for New Leukemia and Lymphoma Drug
www.mskcc.org
The first-ever clinical trial of a new kind of drug, called pirtobrutinib or LOXO-305, has shown promising results in a phase I/II study. Here's hoping 2022 brings these treatment options for CLL patients.![]()
![]()
link.springer.com/article/10.1007/s40265-021-01657-0
link.springer.com
In this review, we examine the literature supporting treatment decision making in the front-line and relapsed/refractory settings for patients with chronic lymphocytic leukemia (CLL). In the front-lin... Dr Brian Koffman on what the omicron variant means to the CLL community and how effective the new treatments will be.![]()
![]()
We are still waiting for the authorities in Ireland to approve some of the antivirals and monoclonal antibodies.![]()
These offer great hope for immunocompromised patients.
bit.ly
Life's lessons are what you get when you don't get what you want. As an immunocompromised chronic lymphocytic leukemia patient, I wanted certainty that I could reengage with the world without playing ...
Uncovering the Value of Real-World Data for Blood Cancer
Published News